期刊文献+

1例隐球菌性脑膜炎合并真菌性食管炎患者的药学监护

Pharmaceutical Care of one Cryptococcal Meningitis with Fungal Esophagitis
下载PDF
导出
摘要 通过对1例隐球菌性脑膜炎合并真菌性食管炎患者的全程优化干预和药学监护,探讨临床药师在合理用药中的作用。临床药师参与药物治疗全过程,并对患者进行药学监护,患者治疗好转出院。临床药师可协助医师制定更加安全、有效、经济、合理的个体化治疗方案,提高患者用药依从性,避免或减轻药品不良反应。 To explore the role of clinical pharmacists in the rational use of medicines by optimizing intervention programs and conducting pharmaceutical care of one cryptococcal meningitis with fungal esophagitis.Clinical pharmacist participated in the whole process of drug therapy and pharmaceutical care for the patient.After treatment,the situation of patient was improved and the patient was discharged from hospital.Clinical pharmacists can help doctors to develop more safe,effective,economic and reasonable individualized treatment programs,and improve drug compliance and avoid or reduce adverse drug reactions.
作者 舒文琳 SHU Wen-lin(Xiamen Hospital of Traditional Chinese Medicine,Department of clinical pharmacy,Xiamen Fujian 361009,China)
出处 《药品评价》 CAS 2019年第4期61-64,共4页 Drug Evaluation
关键词 临床药师 药学监护 隐球菌性脑膜炎 真菌性食管炎 Clinical Pharmacist Pharmaceutical Care Cryptococcal Meningitis Fungal Esophagitis
  • 相关文献

参考文献3

二级参考文献17

  • 1李益龙,陆星华.消化内镜学[M].北京:科学出版社,1995:327.
  • 2Chen SC, O'Donnell S, Gordon S,et al. Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique [J]. J Antimicrob Chemother, 1996, 37(2) :265-273.
  • 3Maxwell MJ, Messer SA, Hollis RJ. Evaluation of etest meth od for determining vorieonazole and amphotericin B MICs for162 clinical isolates of Cryptococcus neoformans [J]. J Clin Microbiol, 2003,41(1): 97-99.
  • 4Sorrell TC. Cryptococcus neoformansvariety gattii[J]. Med Mycol,2001, 39(2): 155-168.
  • 5Steenbergen JN, Casadevall A. Prevalence of Cryptococcus neoformans var. neoformans (serotype D) and Cryptococcus neoformansvar. grubii(serotyo A) isolates in New York City[J]. J Clin Microbiol, 2000, 38(5): 1974-1976.
  • 6Tintelnot K, Schar G, Polak A. Epidemiological data of Cryptococcosisin Austria, Germany and Switzerland: part of the ECMM survey in Europe[J]. Mycoses, 2001,44(9-10):345-350.
  • 7Yamazumi T, Pfaller MA, Messer SA,et al. Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans[J]. J Clin Microbiol, 2003, 41 (1):267-272.
  • 8Brandt ME, Pfaller MA, Hajjeh RA,et al. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformansisolates in human immunodeficiency virus associated cryptococcosis. Cryptocoecal Dieuse Active Surveillance Group[J].J Infect Dis,1996, 174(4) :812-820.
  • 9王晓宇.霉菌性食管炎31例报告.中华消化内镜杂志,2000,17(6):187-187.
  • 10Asayama N,Nagata N,Shimbo T,et akRelationship between clinical factors and severity of esophageal eandidiasis according to Kodsi'sclassification[J].Diseases of the Esophagus, 2014,27(3) : 214-219.

共引文献271

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部